SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000929638-09-001282
Filing Date
2009-07-31
Accepted
2009-07-31 16:25:03
Documents
1
Period of Report
2009-07-23

Document Format Files

Seq Description Document Type Size
1 frm3iridianassetmgmt31jul_ex.html 3  
1 frm3iridianassetmgmt31jul_ex.xml 3 1755
  Complete submission text file 0000929638-09-001282.txt   4020
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 276 POST ROAD WEST WESTPORT CT 06880-4704
Business Address 276 POST RD WEST WESTPORT CT 06880-4704 2033417800
IRIDIAN ASSET MANAGEMENT LLC/CT (Reporting) CIK: 0001033427 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-12957 | Film No.: 09977651